These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 7004618

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Acute renal failure in multiple myeloma.
    Duarte-Amaya A, Mansour NJ.
    Ariz Med; 1972 Jun; 29(6):483-6. PubMed ID: 5035987
    [No Abstract] [Full Text] [Related]

  • 27. [Acute renal failure in multiple myeloma].
    Scharf J, Nahir M, Tatarsky I, Better OS.
    Harefuah; 1974 Jun 02; 86(11):547-8. PubMed ID: 4847992
    [No Abstract] [Full Text] [Related]

  • 28. Five-year outcomes of severe acute kidney injury requiring renal replacement therapy.
    Schiffl H, Fischer R.
    Nephrol Dial Transplant; 2008 Jul 02; 23(7):2235-41. PubMed ID: 18408072
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. High-dose chemotherapy with carboplatin, cyclophosphamide and etoposide and autologous transplantation for multiple myeloma relapsing after a previous transplant.
    Mehta J, Tricot G, Jagannath S, Desikan KR, Siegel D, Singhal S, Munshi N, Vesole D, Mattox S, Bracy D, Barlogie B.
    Bone Marrow Transplant; 1997 Jul 02; 20(2):113-6. PubMed ID: 9244413
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney.
    Grima DT, Airia P, Attard C, Hutchison CA.
    Curr Med Res Opin; 2011 Feb 02; 27(2):383-91. PubMed ID: 21175375
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC, Gertz MA, Fervenza FC, Dispenzieri A, Lacy MQ, Hayman SR, Gastineau DA, Leung N.
    Nephrol Dial Transplant; 2008 Jun 02; 23(6):2052-7. PubMed ID: 18178602
    [Abstract] [Full Text] [Related]

  • 38. Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney.
    Basnayake K, Cheung CK, Sheaff M, Fuggle W, Kamel D, Nakoinz S, Hutchison CA, Cook M, Stoves J, Bradwell AR, Cockwell P.
    J Clin Pathol; 2010 Oct 02; 63(10):884-7. PubMed ID: 20876319
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.